Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.
about
Human Cytochrome P450 1A1 Structure and Utility in Understanding Drug and Xenobiotic MetabolismThe role of AHR-inducible cytochrome P450s in metabolism of polyunsaturated fatty acidsIn vivo biochemical and gene expression analyses of the antioxidant activities and hypocholesterolaemic properties of Tamarindus indica fruit pulp extractDevelopmental regulation and induction of cytochrome P450 2W1, an enzyme expressed in colon tumorsHop (Humulus lupulus L.) extract and 6-prenylnaringenin induce P450 1A1 catalyzed estrogen 2-hydroxylationPreferred binding orientations of phenacetin in CYP1A1 and CYP1A2 are associated with isoform-selective metabolism.Genome-wide RNAi high-throughput screen identifies proteins necessary for the AHR-dependent induction of CYP1A1 by 2,3,7,8-tetrachlorodibenzo-p-dioxin.MspI and Ile462Val polymorphisms in CYP1A1 and overall cancer risk: a meta-analysisDifferential expression of cytochrome P450 enzymes in normal and tumor tissues from childhood rhabdomyosarcoma.Lupinalbin A as the most potent estrogen receptor α- and aryl hydrocarbon receptor agonist in Eriosema laurentii de Wild. (Leguminosae)Cytochrome P450 family 1 inhibitors and structure-activity relationships.SIN3A, generally regarded as a transcriptional repressor, is required for induction of gene transcription by the aryl hydrocarbon receptor.Functional variants in CYP1A1 and GSTM1 are associated with clearance of cervical HPV infection.Structure, function, regulation and polymorphism and the clinical significance of human cytochrome P450 1A2.Collagen density regulates xenobiotic and hypoxic response of mammary epithelial cellsGenetic polymorphisms in the CYP1A1 and CYP1B1 genes and susceptibility to bladder cancer: a meta-analysis.Nitric oxide donor, V-PROLI/NO, provides protection against arsenical induced toxicity in rat liver cells: requirement for Cyp1a1Regulation of CYP1A1 and Inflammatory Cytokine by NCOA7 Isoform 4 in Response to Dioxin Induced Airway Inflammation.Association study of xenobiotic detoxication and repair genes with malignant brain tumors in children.Role of the Aryl Hydrocarbon Receptor in Colon Neoplasia.Co-treatment with indole-3-carbinol and resveratrol modify porcine CYP1A and CYP3A activities and expression.Selective Inhibition of Bakuchicin Isolated from Psoralea corylifolia on CYP1A in Human Liver MicrosomesEstrogen metabolism within the lung and its modulation by tobacco smoke.CYP1A1 regulates breast cancer proliferation and survival.Expression of CYP1A1, CYP1B1 and MnSOD in a panel of human cancer cell linesCigarette smoking, dietary habits and genetic polymorphisms in GSTT1, GSTM1 and CYP1A1 metabolic genes: A case-control study in oncohematological diseases.Thymoquinone regulates gene expression levels in the estrogen metabolic and interferon pathways in MCF7 breast cancer cells.Functional role and tobacco smoking effects on methylation of CYP1A1 gene in prostate cancerBeta-naphthoflavone (DB06732) mediates estrogen receptor-positive breast cancer cell cycle arrest through AhR-dependent regulation of PI3K/AKT and MAPK/ERK signaling.Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis.Role of xenobiotic metabolism in cancer: involvement of transcriptional and miRNA regulation of P450s.Role of cytochrome P-450 genetic polymorphisms in oral carcinogenesis.The anticancer effects of resveratrol: modulation of transcription factors.Ontogeny of mammalian metabolizing enzymes in humans and animals used in toxicological studies.Cytochrome P450 1A1-mediated anticancer drug discovery: in silico findings.Methods for the quantitative evaluation and prediction of CYP enzyme induction using human in vitro systems.Significant association between CYP1A1 T3801C polymorphism and cervical neoplasia risk: a systematic review and meta-analysis.The evolution of our understanding of endo-xenobiotic crosstalk and cytochrome P450 regulation and the therapeutic implications.Proteasome inhibitors - molecular basis and current perspectives in multiple myeloma.DNA methylation and personalized medicine.
P2860
Q27676875-219D576C-87B5-4C41-A686-E0FAAC6BBE8BQ28389473-2D9F4305-A02C-4CF9-A144-64BE80E7E8A3Q28534816-45129D17-4F24-4411-A47E-E7A093987385Q28545761-961D274E-9FF0-4101-82CF-FC3CE4351CA9Q28829558-B9B9D5C6-4C42-4A53-B7E8-0252AEB13B1DQ30561291-332FE7A2-9DE1-43A4-8B36-0DA2325035A4Q31136279-B938E2B3-A81E-497A-B76F-BC282E072F2CQ31147198-CC950818-EB7D-4120-B7B4-2A6DF138A6F3Q31155554-DDBAACBD-5641-4931-BA56-EEF04C7D3959Q34067522-0C5C552B-B640-46A0-947E-18385F88EF59Q34436975-77F8A0EF-CA3D-4586-8580-14C3D47CFF00Q34580421-0EBA8C50-62E2-40E4-82A5-B060E3C5BB4FQ34714582-F68D53FD-AC17-45EA-B9D8-E7939DACC186Q35015993-C72A030D-34A5-4430-ABFB-9AE0DA458810Q35071054-E15709BF-45CB-46E8-A4AD-533A76FDE4F2Q35144348-88269AC9-4B90-4333-9361-851EE9037DF3Q35163743-E2EA23DA-35D4-42B2-986F-D8E808A3B62DQ35307354-30A09AD6-192D-415E-8F9C-57DB941CC407Q35944395-E00DE954-7E09-4812-B642-D01E60ACF7CDQ36102843-73BDC332-CCC1-4A5C-A11D-C577878C236EQ36313788-D60B2E71-7803-438F-8A88-787CC1D5EB15Q36605392-00C24A0A-6C70-4463-B5AE-B12BB979E1C8Q36740713-EEF2F5DA-C4CD-45E0-AEDE-59FC1027525AQ37039023-03F1EAED-BE8D-4674-B3B3-2B116A308D39Q37210214-DF6400C1-1084-48DA-A79C-CF5A5455E858Q37323751-683DE6C4-5866-4A7A-A8B1-A7F1C608BFECQ37404536-C667E4BA-291A-4B4E-8B74-1A9B57A99CDFQ37580177-E8F5A8FE-A269-4D00-B2AA-96E1329F8EAAQ37616066-8654E0E3-8D61-4F1B-A9C6-B3251682AD46Q37662732-822AC701-5341-48D6-9160-93E9C2A89C7EQ37823851-6E94ECE7-56DB-4956-8C31-7B6B839DBEB6Q37906754-4875FC58-2E41-43EC-925B-AF6D0F5A5BD0Q38000616-8F9C5D43-B4CC-4F36-802E-F1B350D9D5D8Q38003479-8A77117B-5C31-491A-B175-C391041B1C1DQ38020235-5CBCF6EB-17DC-495F-B119-88569FF6D803Q38028549-D161D8B6-0143-4ACE-A74F-84C017B18486Q38051275-8487891F-C6A0-4FDB-94D8-62BAA72ADA02Q38128592-ABC49FD6-C70A-46B2-ABF6-4C35A3E309D1Q38202977-BC95C3C6-1F30-4D61-A639-FA4418EDB61FQ38250428-27AA0578-7E29-4EED-A504-B984E160A050
P2860
Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.
@ast
Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.
@en
type
label
Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.
@ast
Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.
@en
prefLabel
Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.
@ast
Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.
@en
P2860
P921
P356
P1433
P1476
Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention.
@en
P2093
Vasilis P Androutsopoulos
P2860
P2888
P356
10.1186/1471-2407-9-187
P407
P5008
P577
2009-06-16T00:00:00Z
P5875
P6179
1032474192